Collagen Stimulating Cosmetic Compositions

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for agents that stimulate procollagen and collagen production in human skin to improve skin appearance and address signs of aging such as wrinkles, sagging, and thinning skin.

Innovation Solution

Cosmetic compositions containing specific compounds with structures according to formulas I(a) and I(b), which stimulate procollagen and collagen production when topically applied, are formulated with cosmetically acceptable vehicles and may include retinoids and alpha- or beta-hydroxy acids to enhance skin health and appearance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If topical agents are applied to stimulate collagen production, then skin appearance and structural integrity are improved, but the complexity of identifying effective compounds increases

Engineering Contradiction:
Improvecollagen production stimulationVSAvoidcompound structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies parameter changes by systematically modifying molecular parameters of the compounds, specifically varying the heterocyclic ring structure (Q), the linker (L), and the substituents (R1-R5) to optimize collagen-stimulating activity. This allows identification of effective compounds through controlled structural variations rather than random screening.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs local quality by focusing on specific regions of the molecular structure that are critical for biological activity. The heterocyclic ring Q and its substituents R1-R5 are identified as key local features that determine the compound's ability to stimulate collagen production, allowing optimization of specific structural elements while maintaining overall molecular framework.

Inventive Principle:
Principle #3Local quality

2Reliability

If new compounds are developed to stimulate procollagen and collagen production, then skin aging signs are treated, but the time and resources required for development increase

Engineering Contradiction:
Improvetreatment effectivenessVSAvoiddevelopment time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent applies preliminary action by pre-defining a structured molecular framework with specific heterocyclic rings and linker groups before testing. This preliminary structural design based on known collagen-stimulating mechanisms accelerates compound development by eliminating random screening and focusing on predetermined active structural elements.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent employs universality by designing a compound class with a core structure that can accommodate multiple substituent variations (R1-R5) while maintaining the fundamental collagen-stimulating function. This universal framework allows a single molecular scaffold to serve multiple therapeutic purposes through systematic substitution.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS8865700B2Collagen stimulators and their use in the treatment of skin
Publication Date: 2014.10.21 AVON PROD INC
  • US8865700B2 patent drawing
  • US8865700B2 patent drawing
  • US8865700B2 patent drawing

AI summary

Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ cosmetic composition comprising novel active agents that enhance collagen production in the skin.